Prospective evaluation of gastrointestinal and genitourinary side effects of pelvic radiotherapy: Association between patient-reported outcomes and clinician-reported outcomes with a view to improving quality of care

盆腔放射治疗的胃肠道和泌尿生殖系统副作用的前瞻性评估：患者报告的结果与临床医生报告的结果之间的关联，以提高护理质量

• 批准号: 467234
• 负责人: Soliman Rania
• 金额: $ 1.27万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=467234&lang=en
• 关键词: Clinician-Reported Outcomes; Electronic Questionnaires; Gastrointestinal; Genitourinary; Patient-Reported Outcomes; Pelvic; Prospective Evaluation; Quality Of Care; Radiotherapy; Real-Time; Side Effects

Most patients who have pelvic radiotherapy (RT) as a treatment for cancer experience some degree of acute gastrointestinal (GI) and genitourinary (GU) toxicities. All patients must have access to well-coordinated, high-quality, multidisciplinary care. If

大多数接受盆腔放射治疗(RT)的癌症患者都经历了不同程度的急性胃肠道(GI)和泌尿生殖系统(GU)毒性。所有患者都必须能够获得协调良好、高质量的多学科护理。如果